Astec Lifesciences (BOM:533138) Change In Receivables : ₹0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2009. Start your Free Trial

What is Astec Lifesciences Change In Receivables?

Astec Lifesciences's change in receivables for the quarter that ended in Mar. 2025 was ₹0 Mil. It means Astec Lifesciences's Accounts Receivable stayed the same from Dec. 2024 to Mar. 2025 .

Astec Lifesciences's change in receivables for the fiscal year that ended in Mar. 2025 was ₹162 Mil. It means Astec Lifesciences's Accounts Receivable declined by ₹162 Mil from Mar. 2024 to Mar. 2025 .

Astec Lifesciences's Accounts Receivable for the quarter that ended in Mar. 2025 was ₹1,474 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Astec Lifesciences's Days Sales Outstanding for the three months ended in Mar. 2025 was 112.56.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Astec Lifesciences's liquidation value for the three months ended in Mar. 2025 was ₹-4,526 Mil.

Astec Lifesciences Change In Receivables Historical Data

The historical data trend for Astec Lifesciences's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Astec Lifesciences Change In Receivables Chart

Astec Lifesciences Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Change In Receivables

Get a 7-Day Free Trial

-309.85

-837.70

1,217.25

-135.32

161.52

Astec Lifesciences Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Astec Lifesciences Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

Astec Lifesciences (BOM:533138) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Astec Lifesciences's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	1474.427	/	1195.27	*	91
=	112.56

2. In Ben Graham's calculation of liquidation value, Astec Lifesciences's accounts receivable are only considered to be worth 75% of book value:

Astec Lifesciences's liquidation value for the quarter that ended in Mar. 2025 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	33.472	-	6464.073	+	0.75 * 1474.427	+	0.5 * 1598.107
=	-4,526

Astec Lifesciences Change In Receivables Related Terms

Thank you for viewing the detailed overview of Astec Lifesciences's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Astec Lifesciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Astec Lifesciences Ltd (BOM:533138) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

ASTEC:India

Address

Eastern Express Highway, Godrej One, 3rd Floor, Pirojshanagar, Vikhroli (East), Mumbai, MH, IND, 400 079

Website

https://www.godrejastec.com

Astec Lifesciences Ltd manufactures & distributes a wide range of Agrochemical active ingredients and pharmaceutical intermediates. The company's products include agrochemicals, such as Triazole Fungicides, Herbicides, and Insecticides. The company is also into Intermediates & Specialty chemicals. Geographically, all the operations of the firm function through India; however, its products are sold in the Indian and overseas markets. It operates in the business segment of Agrochemicals and has a business presence in India and outside India.

Astec Lifesciences Headlines

No Headlines